8-K ·Filed May 11, 2026

GEHC

GE HealthCare Technologies Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001932393-26-000034
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

No trading action warranted. This is a standard annual meeting filing with no surprises — all votes passed overwhelmingly. Monitor for any future 8-Ks related to strategic or financial developments.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
GEHC ▲ +12.88% at T+60d
NEUTRAL call ✓ call won +12.88% · α vs SPY +8.49% · entry $62.29 → $70.31
Entry anchored
May 11, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.54%
$62.29
settled 5mo ago
T+5d
-1.25%
call -1.25% · α -1.33%
$61.51
settled 5mo ago
T+20d
+2.36%
call +2.36% · α +4.09%
$63.76
settled 4mo ago
T+60d
+12.88%
call +12.88% · α +8.49%
$70.31
settled 8w ago

Price Chart

Loading chart...

Executive Summary

GE HealthCare filed an 8-K reporting the results of its May 7, 2026 annual shareholder meeting and two board committee appointments. All director nominees were elected, executive compensation was approved in an advisory vote, and Deloitte & Touche was ratified as auditor. Rodney F. Hochman was appointed independent lead director, and Anne T. Madden was appointed chair of the Nominating and Governance Committee. This is a routine governance filing with no material financial impact.

Key Facts

  • Annual shareholder meeting held May 7, 2026; all eight director nominees elected with strong support (lowest 'for' votes: Kevin A. Lobo at 332,339,981).
  • Advisory vote on executive compensation approved with 351,099,781 'for' votes (96.4% of votes cast excluding broker non-votes).
  • Ratification of Deloitte & Touche LLP as independent auditor for FY2026 approved with 398,257,878 'for' votes.
  • Board appointed Rodney F. Hochman as independent lead director and Anne T. Madden as chair of the Nominating and Governance Committee, effective May 7, 2026.

Financial Impact

No financial impact — routine governance and board committee appointments.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Analyst Consensus
64% bullish (28 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001932393-26-000034
Document: 0001932393-26-000034-index-headers.html0001932393-26-000034
Document: 0001932393-26-000034-index.html0001932393-26-000034
Document: 0001932393-26-000034.txt0001932393-26-000034
7 reports for GEHC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GEHC — sortable, filterable
TypeNow
Jul 29, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$71.90 $73.31▲ +1.96%▼ −3.06%$64.17 (−10.75%)
May 13, 2026
20w ago
Insider Cluster
NEUTRAL ★ 2/10
$64.26 $61.59▼ −4.16%▼ −4.90%$64.17 (−0.14%)
May 11, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$62.29 $63.76▲ +2.36%▲ +4.09%$64.17 (+3.02%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 4/10
$60.84 $62.86▲ +3.32%▼ −1.65%$64.17 (+5.47%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.84 $62.86▲ +3.32%▼ −1.65%$64.17 (+5.47%)
Apr 29, 2026
22w ago
8-K
BEARISH ★ 7/10
$59.49 $63.88▼ −7.39%▼ −1.93%$64.17 (−7.88%)
Mar 19, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$70.35 $74.66▲ +6.13%▼ −1.49%$64.17 (−8.78%)
Showing 7 of 7

US Market Status

Market Open — Closes in 6h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access